Protocol Design White Papers & Case Studies

31. Flexible And Simplified Consent Management 7/31/2025

    Learn about a unified ecosystem integrating eConsent, IRT, eCOA, and ePatient into a seamless workstream designed with a patient-centric approach.

32. Recruiting High-Performing Sites To Beat Forecasted Trial Start Date 7/10/2025

    Explore a partnership that enabled Syneos Health to achieve its enrollment goals, increasing the likelihood of the study's success, and resulting in cost savings and maximized efficiency with minimal delays.

33. RWD, New Technologies Show Potential In Clinical Trial Recruitment 7/10/2025

    Leveraging RWD transforms feasibility and recruitment from reactive processes into strategic drivers of clinical trial success.

34. Fortrea Optimizes Site Matching On Retina Clinical Trials 6/27/2025

    Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.

35. Rapid Results In A High-Stakes Dry Eye Disease Trial 6/26/2025

    This time-sensitive Phase 3 trial in dry eye disease required precision project management leveraging strong site relationships, ophthalmology-specific expertise, and data-driven site selection.

36. Powering Urologic Research With Exclusive Real-World Data 6/25/2025

    These high-quality, fit-for-purpose data modules are tailored to conditions such as prostate cancer, benign prostatic hyperplasia (BPH), non-muscle invasive bladder cancer (NMIBC), and more.

37. Disclosure Management System: Build Or Buy? 6/19/2025

    Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.

38. Completed Clinical Trials Continued To Climb In 2024 6/19/2025

    Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.

39. RWD's Significance In The Largest FDA-Funded IOL Study Of Pediatric Patients 5/28/2025

    With FDA grant support, the American Academy of Ophthalmology and Verana Health conducted the largest real-world study to date on intraocular lens (IOL) use in pediatric cataract patients.

40. Expanding The Role Of External Control Arms 5/28/2025

    External control arms (ECAs) are transforming clinical trials by enhancing efficiency, reducing costs, and addressing ethical challenges.